Tenet Healthcare (NYSE:THC) Releases Quarterly Earnings Results, Beats Expectations By $1.86 EPS

Tenet Healthcare (NYSE:THC) released its earnings results on Thursday. The company reported $6.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86, FiscalAI reports. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.63 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare updated its FY 2026 guidance to 20.300-21.690 EPS.

Tenet Healthcare Stock Up 2.3%

Shares of THC stock traded up $4.50 on Thursday, reaching $199.85. 1,772,108 shares of the company’s stock traded hands, compared to its average volume of 1,249,037. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. Tenet Healthcare has a 12-month low of $146.60 and a 12-month high of $247.21. The business’s 50 day moving average price is $184.41 and its two-hundred day moving average price is $197.37. The company has a market capitalization of $17.22 billion, a P/E ratio of 10.39, a price-to-earnings-growth ratio of 1.63 and a beta of 1.27.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported Q2 EPS of $6.12, beating consensus estimates of $4.26, while revenue of $5.63 billion also topped forecasts. Tenet Healthcare earnings report
• Positive Sentiment: The company raised FY 2026 guidance to EPS of $20.30-$21.69, above the prior consensus estimate of $17.81, and projected revenue of $21.9 billion-$22.5 billion, slightly ahead of expectations. Business Wire article
• Positive Sentiment: Management said strong same-store revenue growth and expense control drove better-than-expected results, reinforcing the view that operational execution remains solid. Business Wire article
• Positive Sentiment: Investors also seem encouraged by Tenet’s improving credit story, including a recent Moody’s upgrade tied to deleveraging progress and greater financial flexibility. Quiver Quantitative article
• Neutral Sentiment: Analyst sentiment remains broadly constructive, with recent price targets and a “Moderate Buy” consensus supporting the stock’s valuation narrative. Analysts’ consensus recommendation article
• Negative Sentiment: Some recent articles highlighted a more cautious analyst forecast, suggesting expectations may still vary after the strong run-up in the shares. Guggenheim forecast article

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. This represents a 25.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director directly owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of THC. Triumph Capital Management bought a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $25,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare in the second quarter worth approximately $35,000. Meeder Asset Management Inc. increased its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after purchasing an additional 114 shares during the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after purchasing an additional 89 shares during the last quarter. Finally, Wilkerson Advisory Group LLC acquired a new position in Tenet Healthcare during the fourth quarter worth $62,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. TD Cowen lowered their price objective on shares of Tenet Healthcare from $242.00 to $233.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Barclays lifted their price target on shares of Tenet Healthcare from $238.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 8th. Stephens cut their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research report on Monday, May 4th. Wells Fargo & Company lifted their price target on Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Finally, Guggenheim cut their price objective on Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating on the stock in a report on Monday. Seventeen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $244.84.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.